PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response

Oncogene

Volumn 26, Issue 24, 2007, Pages 3451-3461

  Ayllon V ^a   O'Connor, R ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

H2AX; IGF IR; p38; PBK; Tumour growth

Indexed keywords

AGAR; DNA; EPIDERMAL GROWTH FACTOR; HISTONE H2AX; MITOGEN ACTIVATED PROTEIN KINASE P38; PDZ BINDING KINASE; PDZ PROTEIN; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; SOMATOMEDIN C; T LAK CELL ORIGINATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AGAR MEDIUM; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN; CELL SURVIVAL; CELL TRANSFORMATION; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA INTERFERENCE;

ANIMALS; CARCINOGENICITY TESTS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA DAMAGE; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; HISTONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 34249308194     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210142     Document Type: Article

References (49)

1. Abe Y, Matsumoto S, Kito K, Ueda N. (2000). Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem 275: 21525-21531.
2. Bartucci M, Morelli C, Mauro L, Ando S, Surmacz E. (2001). Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 61: 6747-6754.
3. Cleaver JE. (2005). Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5: 564-573.
4. Cote S, Simard C, Lemieux R. (2002). Regulation of growth-related genes by interleukin-6 in murine myeloma cells. Cytokine 20: 113-120.
5. Dendouga N, Gao H, Moechars D, Janicot M, Vialard J, McGowan CH. (2005). Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis. Mol Cell Biol 25: 7569-7579.
6. Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R et al. (2005). PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J Neurosci 25: 10773-10785.
7. Dupont J, Dunn SE, Barrett JC, LeRoith D. (2003). Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression. Recent Prog Horm Res 58: 325-342.
8. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. (2004). H2AX: the histone guardian of the genome. DNA Repair (Amsterdam) 3: 959-967.
9. Friedmann B, Caplin M, Hartley JA, Hochhauser D. (2004). Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Clin Cancer Res 10: 6476-6486.
10. Fujibuchi T, Abe Y, Takeuchi T, Ueda N, Shigemoto K, Yamamoto H et al. (2005). Expression and phosphorylation of TOPK during spermatogenesis. Dev Growth Differ 47: 637-644.
11. Gaudet S, Branton D, Lue RA. (2000). Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl Acad Sci USA 97: 5167-5172.
12. Heron-Milhavet L, Karas M, Goldsmith CM, Baum BJ, LeRoith D. (2001). Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair. J Biol Chem 276: 18185-18192.
13. Heron-Milhavet L, LeRoith D. (2002). Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage. J Biol Chem 277: 15600-15606.
14. Hofmann F, Garcia-Echeverria C. (2005). Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today 10: 1041-1047.
15. Huang C, Jacobson K, Schaller MD. (2004). MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
16. Kiely PA, Leahy M, O'Gorman D, O'Connor R. (2005). RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J Biol Chem 280: 7624-7633.
17. Kim MS, Lee EJ, Kim HR, Moon A. (2003). p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 63: 5454-5461.
18. Lee-Kwon W, Park D, Bernier M. (1998). Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1. Exp Cell Res 241: 458-466.
19. Lisby M, Rothstein R. (2004). DNA damage checkpoint and repair centers. Curr Opin Cell Biol 16: 328-334.
20. Loughran G, Healy NC, Kiely PA, Huigsloot M, Kedersha NL, O'Connor R. (2005a). Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth. Mol Biol Cell 16: 1811-1822.
21. Loughran G, Huigsloot M, Kiely PA, Smith LM, Floyd S, Ayllon V et al. (2005b). Gene expression profiles in cells transformed by overexpression of the IGF-I receptor. Oncogene 24: 6185-6193.
22. Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y. (2001). Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of ATM kinase. Oncogene 20: 4029-4040.
23. Madhusudan S, Hickson ID. (2005). DNA repair inhibition: a selective tumour targeting strategy. Trends Mol Med 11: 503-511.
24. Maldonado C, Cea P, Adasme T, Collao A, Diaz-Araya G, Chiong M et al. (2005). IGF-1 protects cardiac myocytes from hyperosmotic stress-induced apoptosis via CREB. Biochem Biophys Res Commun 336: 1112-1118.
25. Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE. (2006). H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc Natl Acad Sci USA 103: 9891-9896.
26. Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N et al. (2004). Characterization of a MAPKK-like protein kinase TOPK. Biochem Biophys Res Commun 325: 997-1004.
27. Mauro L, Surmacz E. (2004). IGF-I receptor, cell-cell adhesion, tumour development and progression. J Mol Histol 35: 247-253.
28. Mikhailov A, Shinohara M, Rieder CL. (2005). The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle 4: 57-62.
29. Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T et al. (2002). Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J Biol Chem 277: 42480-42487.
30. Nandi A, Tidwell M, Karp J, Rapoport AP. (2004). Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells. Blood Cells Mol Dis 32: 240-245.
31. Nandi AK, Rapoport AP. (2006). Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF. Leuk Res 30: 437-447.
32. O'Connor R. (2003). Regulation of IGF-I receptor signaling in tumor cells. Horm Metab Res 35: 771-777.
33. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. (2000). A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10: 886-895.
34. Risinger MA, Groden J. (2004). Crosslinks and crosstalk: human cancer syndromes and DNA repair defects. Cancer Cell 6: 539-545.
35. Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM. (2005). Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther 12: 90-100.
36. Sartor CI. (2004). Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol 1: 80-87.
37. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R. (1993). Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90: 11217-11221.
38. Shen WH, Yin Y, Broussard SR, McCusker RH, Freund GG, Dantzer R et al. (2004). Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J Biol Chem 279: 7438-7446.
39. Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D et al. (2001). PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis 27: 825-829.
40. Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J et al. (2005). The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 7: 195-201.
41. Speit G, Hartmann A. (1999). The comet assay (single-cell gel test). A sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol Biol 113: 203-212.
42. Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA. (2004). ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64: 2390-2396.
43. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. (2005). MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123: 1213-1226.
44. Surmacz E. (2003). Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 22: 6589-6597.
45. Trojanek J, Ho T, Del Valle L, Nowicki M, Wang JY, Lassak A et al. (2003). Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol 23: 7510-7524.
46. Vincent AM, Feldman EL. (2002). Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12: 193-197.
47. Wang WD, Chen ZT, Li DZ, Cao ZH, Sun SL, Pu P et al. (2005). Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients. Clin Cancer Res 11: 5140-5145.
48. Yacoub A, McKinstry R, Hinman D, Chung T, Dent P, Hagan MP. (2003). Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling. Radiat Res 159: 439-452.
49. Yang S, Chintapalli J, Sodagum L, Baskin S, Malhotra A, Reiss K et al. (2005). Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol 289: F1144-F1152.